The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Peter M. A. Calverley

School of Ageing and Chronic Disease

University Hospital Aintree

Lower Lane

Liverpool

UK

[email]@liverpool.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • School of Ageing and Chronic Disease, University Hospital Aintree, Lower Lane, Liverpool, UK. 1999 - 2012
  • Pulmonary and Rehabilitation Research Group, Dept of Medicine, Clinical Sciences, University Hospital Aintree, United Kingdom. 2010
  • School of Clinical Sciences, Liverpool, UK. 2009

References

  1. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Albert, P., Agusti, A., Edwards, L., Tal-Singer, R., Yates, J., Bakke, P., Celli, B.R., Coxson, H.O., Crim, C., Lomas, D.A., Macnee, W., Miller, B., Rennard, S., Silverman, E.K., Vestbo, J., Wouters, E., Calverley, P. Thorax (2012) [Pubmed]
  2. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Calverley, P.M., Stockley, R.A., Seemungal, T.A., Hagan, G., Willits, L.R., Riley, J.H., Wedzicha, J.A. Chest (2011) [Pubmed]
  3. Cardiovascular events in patients with COPD: TORCH study results. Calverley, P.M., Anderson, J.A., Celli, B., Ferguson, G.T., Jenkins, C., Jones, P.W., Crim, C., Willits, L.R., Yates, J.C., Vestbo, J. Thorax (2010) [Pubmed]
  4. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Calverley, P.M., Kuna, P., Monsó, E., Costantini, M., Petruzzelli, S., Sergio, F., Varoli, G., Papi, A., Brusasco, V. Respir. Med (2010) [Pubmed]
  5. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Calverley, P.M., Rabe, K.F., Goehring, U.M., Kristiansen, S., Fabbri, L.M., Martinez, F.J. Lancet (2009) [Pubmed]
  6. Leaving invasive ventilation behind. Calverley, P.M. Lancet (2009) [Pubmed]
  7. One-year treatment with mometasone furoate in chronic obstructive pulmonary disease. Calverley, P.M., Rennard, S., Nelson, H.S., Karpel, J.P., Abbate, E.H., Stryszak, P., Staudinger, H. Respir. Res. (2008) [Pubmed]
  8. COPD: what is the unmet need?. Calverley, P.M. Br. J. Pharmacol. (2008) [Pubmed]
  9. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Calverley, P.M., Sanchez-Toril, F., McIvor, A., Teichmann, P., Bredenbroeker, D., Fabbri, L.M. Am. J. Respir. Crit. Care Med. (2007) [Pubmed]
  10. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. Calverley, P.M., Anderson, J.A., Celli, B., Ferguson, G.T., Jenkins, C., Jones, P.W., Yates, J.C., Vestbo, J. N. Engl. J. Med. (2007) [Pubmed]
  11. What have we learned from large drug treatment trials in COPD?. Calverley, P.M., Rennard, S.I. Lancet (2007) [Pubmed]
  12. The severity of airways obstruction as a determinant of treatment response in COPD. Calverley, P., Pauwels, R.A., Jones, P.W., Anderson, J.A., Vestbos, J. Int. J. Chron. Obstruct. Pulmon. Dis (2006) [Pubmed]
  13. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? Calverley, P.M., Scott, S. COPD (2006) [Pubmed]
  14. The role of corticosteroids in chronic obstructive pulmonary disease. Calverley, P.M. Semin. Respir. Crit. Care. Med (2005) [Pubmed]
  15. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Calverley, P., Pauwels Dagger, R., Löfdahl, C.G., Svensson, K., Higenbottam, T., Carlsson, L.G., Ståhl, E. Eur. Respir. J. (2005) [Pubmed]
  16. Development of a population-based screening questionnaire for COPD. Calverley, P.M., Nordyke, R.J., Halbert, R.J., Isonaka, S., Nonikov, D. COPD (2005) [Pubmed]
  17. Minimal clinically important difference--exacerbations of COPD. Calverley, P.M. COPD (2005) [Pubmed]
  18. Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease. Calverley, P.M. Proc. Am. Thorac. Soc (2004) [Pubmed]
  19. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease. Calverley, P.M. Proc. Am. Thorac. Soc (2004) [Pubmed]
  20. Conclusion. Lessons from the novel D2 dopamine receptor, beta2-adrenoceptor agonist, Viozan: chronic obstructive pulmonary disease and drug development implications. Calverley, P., Keating, E.T., Goldman, M., Casty, F. Respir. Med (2003) [Pubmed]
  21. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Calverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., Maden, C. Lancet (2003) [Pubmed]
  22. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Calverley, P.M., Burge, P.S., Spencer, S., Anderson, J.A., Jones, P.W. Thorax (2003) [Pubmed]
  23. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Calverley, P.M., Lee, A., Towse, L., van Noord, J., Witek, T.J., Kelsen, S. Thorax (2003) [Pubmed]
  24. Withdrawal from treatment as an outcome in the ISOLDE study of COPD. Calverley, P.M., Spencer, S., Willits, L., Burge, P.S., Jones, P.W. Chest (2003) [Pubmed]
  25. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Calverley, P.M., Boonsawat, W., Cseke, Z., Zhong, N., Peterson, S., Olsson, H. Eur. Respir. J. (2003) [Pubmed]
  26. The management of severe chronic obstructive pulmonary disease. Calverley, P.M. J. R. Coll. Physicians. Lond (1999) [Pubmed]
 
WikiGenes - Universities